Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic (MEC) or highly emetogenic (HEC) chemotherapies in patients with lung cancer

Category Primary study
JournalEuropean Journal of Cancer, Supplement
Year 2009
This article has no abstract
Epistemonikos ID: fecd6f45984b6d9e19e913ef81652c527c84d572
First added on: Mar 01, 2025